InsiderCEO
Eric Venker Insider Trading Activity
Every SEC Form 4 transaction reported by Eric Venker, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Eric Venker buying or selling?
Eric Venker reported 0 open-market buys ($0) and 54 sells ($180.3M) across 54 Form 4 filings at 2 companies — a net selling position of $180.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 6, 2026)
Total Form 4 filings
54
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (54)
$180.3M
Insider sentiment
Net sellingNet insider flow of $180.3M in net selling, filed between Mar 29, 2022 – Jul 6, 2026.
Companies Eric Venker files for
Recent Eric Venker transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | IMVT | Chief Executive Officer | Sale | 3.1K | $119.0K |
| Jun 26, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $6.6M |
| May 22, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $6.1M |
| Apr 22, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.9M |
| Apr 3, 2026 | IMVT | Chief Executive Officer | Sale | 14.2K | $342.9K |
| Mar 19, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.6M |
| Feb 18, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.3M |
| Jan 15, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $4.4M |
| Dec 30, 2025 | ROIV | President & Immunovant CEO | Sale | 275.0K | $6.2M |
| Dec 12, 2025 | ROIV | President & Immunovant CEO | Sale | 200.0K | $4.2M |
| Oct 18, 2025 | ROIV | President & Immunovant CEO | Sale | 851.4K | $14.5M |
| Oct 15, 2025 | ROIV | President & Immunovant CEO | Sale | 125.7K | $2.0M |
| Oct 9, 2025 | ROIV | President & Immunovant CEO | Sale | 665.2K | $10.8M |
| Sep 24, 2025 | ROIV | President & Immunovant CEO | Sale | 1.7M | $25.5M |
| Aug 23, 2025 | ROIV | President & Immunovant CEO | Sale | 100.0K | $1.2M |
| Jul 24, 2025 | ROIV | President & Immunovant CEO | Sale | 100.0K | $1.2M |
| Jun 25, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M |
| Jun 5, 2025 | ROIV | President & COO | Sale | 1.0M | $11.2M |
| May 23, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M |
| Apr 23, 2025 | ROIV | President & COO | Sale | 100.0K | $1.0M |
| Mar 25, 2025 | ROIV | President & COO | Sale | 750.0K | $8.2M |
| Feb 25, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M |
| Feb 15, 2025 | ROIV | President & COO | Sale | 435.4K | $4.6M |
| Jan 23, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M |
| Jan 1, 2025 | ROIV | President & COO | Sale | 354.6K | $4.1M |
Showing the 25 most recent filings of 54. Screen every filing.
Eric Venker insider trading FAQ
Is Eric Venker buying or selling?
Across 54 SEC Form 4 filings, Eric Venker reported 0 open-market purchases totaling $0 and 54 sales totaling $180.3M — a net selling position of $180.3M.
Which companies does Eric Venker file Form 4s for?
Eric Venker has reported insider transactions at 2 companies, most often Roivant Sciences Ltd. (ROIV), Immunovant, Inc. (IMVT).
How far back does Eric Venker's filing history go?
Trabud holds Eric Venker's SEC Form 4 filings from Mar 29, 2022 – Jul 6, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Eric Venker's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Eric Venker and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener